Literature DB >> 2765818

Operative mortality following surgery for colorectal cancer.

J L Canivet1, P Damas, C Desaive, M Lamy.   

Abstract

From 1973 to 1986 at the Baviere Hospital, University of Liège, 476 patients underwent surgery for colorectal cancers. The overall operative mortality rate was 13.4 per cent. The following postoperative life-threatening complications occurred: myocardial infarction (14 per cent of the postoperative deaths) during the first three postoperative days; bronchopneumonia (27 per cent of the postoperative deaths) mainly during the first postoperative week; pulmonary embolism (17 per cent of the postoperative deaths) mainly during the second postoperative week; anastomotic leakage and cerebrovascular accident (14 and 8 per cent of the postoperative deaths respectively) mainly during the third and fourth postoperative weeks. Specific risk factors were chronic obstructive airways disease associated with a higher incidence of postoperative bronchopneumonia, and previous myocardial infarction associated with postoperative myocardial infarction and pulmonary embolism. General risk factors were old age and emergency procedure, both of which were associated with a higher incidence of infectious complications. The operative mortality rate fell from 20.1 per cent in the 1973-79 period to 7.8 per cent in the 1980-86 period.

Entities:  

Mesh:

Year:  1989        PMID: 2765818     DOI: 10.1002/bjs.1800760734

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

1.  Coloanal anastomosis after resection of low rectal cancer in the elderly.

Authors:  C Huguet; J Harb; S Bona
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  Assessing outcomes following surgery for colorectal cancer using quality of care indicators.

Authors:  Omar Vergara-Fernandez; Carol J Swallow; J Charles Victor; Brenda I O'Connor; Robert Gryphe; Helen M MacRae; Zane Cohen; Robin S McLeod
Journal:  Can J Surg       Date:  2010-08       Impact factor: 2.089

3.  Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program.

Authors:  W E Longo; K S Virgo; F E Johnson; T P Wade; A M Vernava; M A Phelan; W G Henderson; J Daley; S F Khuri
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

Review 4.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

5.  Nicorandil-associated ulceration of the gastrointestinal tract: side effects requiring surgical intervention.

Authors:  I M Shapey; D Agbamu; N Newall; L V Titu
Journal:  Int J Colorectal Dis       Date:  2015-01-13       Impact factor: 2.571

6.  Long-term Postprocedural Outcomes of Palliative Emergency Stenting vs Stoma in Malignant Large-Bowel Obstruction.

Authors:  Jonathan S Abelson; Heather L Yeo; Jialin Mao; Jeffrey W Milsom; Art Sedrakyan
Journal:  JAMA Surg       Date:  2017-05-01       Impact factor: 14.766

7.  [Morbidity and mortality after elective resections of colorectal cancers].

Authors:  B Böhm; K Nouchirvani; H P Hucke; W Stock
Journal:  Langenbecks Arch Chir       Date:  1991

8.  Colorectal cancer prognosis twenty years later.

Authors:  Luis Bujanda; Cristina Sarasqueta; Elisabeth Hijona; Lander Hijona; Angel Cosme; Ines Gil; Jose Luis Elorza; Jose I Asensio; Santiago Larburu; José M Enríquez-Navascués; Rodrigo Jover; Francesc Balaguer; Xavier Llor; Xavier Bessa; Montserrat Andreu; Artemio Paya; Antoni Castells
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

9.  [Colorectal carcinoma. Which factors are decisive for development of postoperative complications?].

Authors:  C Tonus; O Keller; R Kropp; H Nier
Journal:  Langenbecks Arch Chir       Date:  1996

10.  Operative mortality in carcinoma of the rectum. Results of the German Multicentre Study.

Authors:  H Kessler; P Hermanek; H Wiebelt
Journal:  Int J Colorectal Dis       Date:  1993-09       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.